April 7, 2017

April 07, 2017

Moffitt Foundation hosts kickoff reception for upcoming luncheon
East County Observer – April 6
About 30 supporters of Moffitt Cancer Center gathered April 5 at Michael’s Wine Cellar for an intimate celebration in preparation for the Moffitt Cancer Center Luncheon.
The center’s main fundraising event will take place on Nov. 1 at Michael’s on the Bay at Selby Gardens.

More than 80% of patients respond to CAR T-Cell Therapy in Phase II NHL Trial
Targeted Oncology – April 6
“This is the first pivotal trial of anti-CD19 CAR T-cells in refractory, aggressive non-Hodgkin lymphoma, and the results demonstrated a significant benefit for patients lacking curative options,” co-lead investigator Frederick L. Locke, MD, said in presenting the data.

Trigaux: Can Florida find right mojo to lure top millennials? One survey doubts it
Tampa Bay Times – April 6
Ruan Cox Jr., an industry alliances development associate a Moffitt Cancer Center in Tampa, is also a millennial ambassador with StandUp Tampa, working to attract talented millennials to this market. 

New Experimental Therapy Found to Cure Non-Hodgkin's Lymphoma
Christian Post – April 6
According to Dr. Frederick Locke, an oncologist from the Moffitt Cancer Center in Tampa, Florida, the body has different soldiers that have the ability to fight war, and what CAR-T therapy does is take out all these soldiers, give them a global positioning system (GPS) and tell them that they when they are put back in, they should go attack the enemy called lymphoma.

FDA Panel Backs Abuse-Deterrent Immediate-Release Opioid
Medpage Today – April 5
David Craig, PharmD, of Moffitt Cancer Center in Tampa, Fla., said he considers such potential for adverse events a "real concern for products like this, especially when they're not intended to be used that way. It's hard to control for those problems, but I would support a black box warning for the potential harm from injecting."

Antwan Dixon resolute before bone marrow transplant from father, Anthony
News Press – April 5
One of the blankets he has with him now at Moffitt Cancer Center in Tampa – where the former South Fort Myers High receiver is undergoing intense chemotherapy in preparation for a bone marrow transplant next week from his father, former Wolfpack coach Anthony Dixon – has Superman’s famed red and yellow shield on it.

New Cancer Strategy
WTAJ – April 5
Frederick Locke, M.D., an oncologist at Moffitt Cancer Center in Tampa, Florida, detailed, "It's pretty amazing to see patients go into remission that we really had low hope of standard therapies working." 

CAR T-Cell Study in NHL Patients Shows Activity and Feasibility
Clinical Oncology News – April 5
These data suggest that axicabtagene ciloleucel could address an important unmet need in patients with refractory NHL, according to Frederick L. Locke, MD, a co-lead investigator for this trial and the director of research for the Immune Cell Therapy Program at Moffitt Cancer Center, in Tampa, Fla.

Senate amendment quickens pace for medical marijuana treatment center growth
Clay Today – April 5
Committee members will also be asked to vote on an amendment Monday that would establish the Coalition for Medical Marijuana Research and Education within the H. Lee Moffitt Cancer Center and Research Institute.

Drug Free America pushes back on ‘dangers’ of medical marijuana
Sunshine State News – April 5
The Senate proposal would also set up a research facility at the Moffitt Cancer Center in Tampa to independently test marijuana and would ban the sale of medical pot to minors. 

Immunomedics says IMMU-132 hits targets in small cell lung cancer
Fierce Biotech – April 5
Jhanelle Gray, M.D. of H. Lee Moffitt Cancer Center and Research Institute in Tampa, Florida—who presented the data this week at the American Association of Cancer Research (AACR) meeting in Washington D.C.—said that the results are "encouraging" and important since SCLC is "still a lethal disease, especially in the population that is chemo-resistant to first-line therapy."

Free Screenings for Head and Neck Cancer
Tampa Bay’s Morning Blend  – April 4
April is Head and Neck Cancer Awareness month and on Friday, April 7, Moffitt Cancer Center is holding free head and neck cancer screenings from 8 a.m.- noon. 

Health Beat: CAR T therapy for cancer treatment
WFMZ – April 4
"It's pretty amazing to see patients go into remission that we really had low hope of standard therapies working," said Dr. Frederick Locke, an oncologist at Moffitt Cancer Center in Tampa, Florida.

CAR T-Cell Response Rate Tops 80% in NHL Trial
OncLive – April 4
“This is the first pivotal trial of anti-CD19 CAR T-cells in refractory, aggressive non-Hodgkin lymphoma, and the results demonstrated a significant benefit for patients lacking curative options,” co-lead investigator Frederick L. Locke, MD, said in presenting the data.

Senate clears medical marijuana bill, expanding grower licenses
Tampa Bay Times – April 3
Among the key changes to the legislation (SB 406):
* Speeding up new licenses. The bill now grants five new licenses by October, plus four more for every 75,000 patients registered to use medical marijuana in the state.
* Creating a research program at Moffitt Cancer Center.

Senate panel passes medical marijuana plan
Sun Sentinel – April 3
Along with Artiles’ requirement for independent testing of marijuana, the Bradley bill also now creates a new medical marijuana research group at the Moffitt Cancer Center in Tampa.

Senate panel OKs medical marijuana bill, speeds up pace for new licenses
SaintPetersBlog – April 3
The committee also adopted amendments to allow the Department of Health to charge “a reasonable fee associated with the issuance and renewal of patient and caregiver identification cards,” an amendment that would require medical marijuana be tested by an independent testing lab, and an amendment that would establish the Coalition for Medical Marijuana Research and Education within the H. Lee Moffitt Cancer Center and Research Institute.

Senate Medical Marijuana Bill Passes Senate Health Committee
Capitol News Service – April 3
The Bill also calls for the formation of a Medical Marijuana Research and Education Board which will guide marijuana policy based on research from the H. Lee Moffitt Cancer Center.

Senate Committee Green Lights Bill to Regulate Medical Marijuana
Sunshine State News – April 3
One of the new amendments would create a coalition for medical marijuana research through Tampa’s H. Lee Moffitt Center and Research Institute, one of the top medical research centers in the state.

Blood Cancer Breakthrough
KTIV – April 3
"These are patients who are absolutely not responding to standard of care chemotherapies," says Dr. Frederick Locke of Moffitt Cancer Center. Moffitt was part of the study of an immunotherapy called CAR-T.

CAR-T race heats up as Kite, Novartis complete filings to FDA
BioPharmaDive – April 2
At Sunday's AACR presentation, Frederick Locke, a ZUMA-1 co-lead investigator from the Moffitt Cancer Center, attributed the decline in adverse event rates to increased comfort with CAR-T treatment and its side effects among physicians managing these patients.

Doctors announce breakthrough in blood cancer treatment
NBC Nightly News With Lester Holt – March 31
"These are patients who are absolutely not responding to standard of care chemotherapies," says Dr. Frederick Locke of Moffitt Cancer Center. Moffitt was part of the study of an immunotherapy called CAR-T.

Promising new lymphoma treatment gets fast-tracked by FDA
CBS Evening News With Scott Pelley – March 31
On Friday, Moffitt Cancer Center and MD Anderson reported test results of 101 patients with advanced lymphoma who had failed previous therapy and were treated with CAR-T.

Gene therapy reverses cancer in one-third of patients
Irish Medical News – March 31
Dr. Fred Locke, co-lead of the study and an expert in blood cancer at Moffitt Cancer Center in Tampa described these results as “fantastic”. Kite Pharma is the US pharmaceutical company behind the treatment that consists of filtering immune T-cells from the blood of the patient as a means of creating a ‘living drug’.

###

Please note we cannot guarantee the accuracy or availability of links. The stories belong to the respective publishers, and links may expire. Some news sites require you to register and select a password in order to retrieve articles, but most usually do not charge a fee to retrieve these news stories.